Natalie June Medlicott

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Douglas Pharmaceuticals Limited. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalie June Medlicott. Retrieved from https://idiyas.com/inventor/natalie-june-medlicott

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 57(Granted Patents)

Company Filing History:

11 out of 19

Douglas Pharmaceuticals Limited

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12611386 - Extended release pharmaceutical formulation (2026-04-28),

2. 12472146 - Extended release pharmaceutical formulation (2025-11-18),

3. 12350379 - Extended release pharmaceutical formulation and methods of treatment (2025-07-08),

4. 12350378 - Extended release pharmaceutical formulation and methods of treatment (2025-07-08),

5. 12128140 - Extended release pharmaceutical formulation (2024-10-29),

6. 12090123 - Extended release pharmaceutical formulation (2024-09-17),

7. 11471416 - Extended release pharmaceutical formulation and methods of treatment (2022-10-18),

8. 11471415 - Extended release pharmaceutical formulation and methods of treatment (2022-10-18),

9. 11045424 - Extended release pharmaceutical formulation (2021-06-29),

10. 10869838 - Extended release pharmaceutical formulation (2020-12-22),

11. 10744094 - Extended release pharmaceutical formulation (2020-08-18),

12. 10441544 - Extended release pharmaceutical formulation (2019-10-15),

Title: The Innovative Contributions of Natalie June Medlicott

Introduction

Natalie June Medlicott is a prominent inventor based in Dunedin, New Zealand. She has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release formulations. With a total of 10 patents to her name, Medlicott's work focuses on addressing complex mental health issues.

Latest Patents

Among her latest patents is an oral extended release pharmaceutical formulation designed for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia. This innovative formulation aims to provide patients with more effective treatment options for their mental health challenges.

Career Highlights

Throughout her career, Medlicott has worked with notable companies, including Douglas Pharmaceuticals Limited and Douglas Pharmaceuticals Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to the advancement of pharmaceutical science.

Collaborations

Medlicott has collaborated with esteemed colleagues such as Paul William Glue and Peter William Surman. These partnerships have further enriched her research and development efforts in the pharmaceutical industry.

Conclusion

Natalie June Medlicott's innovative work in pharmaceutical formulations highlights her dedication to improving mental health treatment. Her contributions continue to make a significant impact in the field, showcasing the importance of innovation in addressing complex health issues.

Profile summary based on public USPTO records.